Hattori Kohei, Tago Kenji, Memezawa Shiori, Ochiai Arisa, Sawaguchi Sui, Kato Yukino, Sato Takanari, Tomizuka Kazuma, Ooizumi Hiroaki, Ohbuchi Katsuya, Mizoguchi Kazushige, Miyamoto Yuki, Yamauchi Junji
Laboratory of Molecular Neurology Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
Department of Biochemistry, Jichi Medical University, Shimotsuke, Tochigi 321-0498, Japan.
Medicines (Basel). 2021 Feb 1;8(2):9. doi: 10.3390/medicines8020009.
Genetic hypomyelinating diseases are a heterogeneous group of disorders involving the white matter. One infantile hypomyelinating leukoencephalopathy is associated with the homozygous variant (Cys4-to-Ser (C4S)) of the 3 gene. We observed that in mouse oligodendroglial FBD-102b cells, the C4S mutant proteins but not the wild type ones of C11orf73 are microscopically localized in the lysosome. And, they downregulate lysosome-related signaling in an immunoblotting technique. The C4S mutant proteins specifically interact with Filamin A, which is known to anchor transmembrane proteins to the actin cytoskeleton; the C4S mutant proteins and Filamin A are also observed in the lysosome fraction. While parental FBD-102b cells and cells harboring the wild type constructs exhibit morphological differentiation, cells harboring C4S mutant constructs do not. It may be that morphological differentiation is inhibited because expression of these C4S mutant proteins leads to defects in the actin cytoskeletal network involving Filamin A. The findings that leukoencephalopathy-associated C11ORF73 mutant proteins specifically interact with Filamin A, are localized in the lysosome, and inhibit morphological differentiation shed light on the molecular and cellular pathological mechanisms that underlie infantile hypomyelinating leukoencephalopathy.
遗传性髓鞘形成低下疾病是一组涉及白质的异质性疾病。一种婴儿型髓鞘形成低下性白质脑病与C11orf73基因的纯合变体(Cys4突变为Ser(C4S))有关。我们观察到,在小鼠少突胶质细胞FBD - 102b细胞中,C11orf73的C4S突变蛋白而非野生型蛋白在显微镜下定位于溶酶体。并且,它们在免疫印迹技术中下调与溶酶体相关的信号传导。C4S突变蛋白特异性地与细丝蛋白A相互作用,细丝蛋白A已知可将跨膜蛋白锚定到肌动蛋白细胞骨架上;在溶酶体部分也观察到C4S突变蛋白和细丝蛋白A。虽然亲代FBD - 102b细胞和携带野生型构建体的细胞表现出形态分化,但携带C4S突变构建体的细胞则没有。可能是因为这些C4S突变蛋白的表达导致涉及细丝蛋白A的肌动蛋白细胞骨架网络出现缺陷,从而抑制了形态分化。与白质脑病相关的C11ORF73突变蛋白特异性地与细丝蛋白A相互作用、定位于溶酶体并抑制形态分化,这些发现揭示了婴儿型髓鞘形成低下性白质脑病的分子和细胞病理机制。